VivoSeq
Other

Erector Spinae Block

0

Pipeline Programs

4

Active Trials

0

Companies Involved

Erector Spinae Block is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

82/100

Attrition Rate

11/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

19

clinical trials

Completed9 · 47%
Unknown status4 · 21%
Recruiting3 · 16%
Terminated2 · 11%
Not yet recruiting1 · 5%

Trial Activity

19 trials

Erector Spinae Block for Thoracic Surgery
Recruiting·GGeorge Washington University·Phase 4·NCT05521789·70 enrolled
Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients
Completed··Phase 3·NCT04613830·60 enrolled
Continuous Erector Spinae Block Versus Continuous Paravertebral Block
Terminated··Phase 3·NCT03768440·100 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)